Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNGX Soligenix, Inc.

未开盘 07-02 16:00:00 EDT

2.27

-0.20

-8.10%

盘后2.27

+0.000.00%

19:48 EDT

最高2.56	最低2.00	成交量12.74万
今开2.46	昨收2.47	日振幅22.48%
总市值224.16万	流通市值223.56万	总股本98.75万
成交额28.95万	换手率12.93%	流通股本98.48万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":2.27,"timestamp":1719950400000,"preClose":2.47,"halted":0,"volume":127383,"hourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.27,"latestTime":"19:48 EDT","volume":267,"amount":606.26,"timestamp":1719964132845},"delay":0,"floatShares":984825,"shares":987489,"eps":-11.611136,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.2,"latestTime":"07-02 16:00:00 EDT","open":2.46,"high":2.5553,"low":2,"amount":289495.8794562,"amplitude":0.224818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-11.611136,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"adjPreClose":2.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.51,"preClose":2.49,"latestTime":"09:29 EDT","volume":201,"amount":511.3252065,"timestamp":1719926992063},"postHourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.27,"latestTime":"19:48 EDT","volume":267,"amount":606.26,"timestamp":1719964132845},"volumeRatio":0.543937},"requestUrl":"/m/hq/s/SNGX/wiki","defaultTab":"wiki","newsList":[{"id":"2439998463","title":"Soligenix Inc-打算对其普通股进行反向分割拆分后每16股分拆前股票的比例为1股","url":"https://stock-news.laohu8.com/highlight/detail?id=2439998463","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439998463?lang=zh_cn&edition=full","pubTime":"2024-05-31 19:36","pubTimestamp":1717155418,"startTime":"0","endTime":"0","summary":"Soligenix Inc-打算对其普通股进行反向分割拆分后每16股分拆前股票的比例为1股","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531193704957f6841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531193704957f6841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2435322497","title":"Soligenix Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435322497","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435322497?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:32","pubTimestamp":1715603522,"startTime":"0","endTime":"0","summary":"   * Soligenix Inc   报告了截至1月底的季度调整后每股亏损18美分，高于去年同期的每股-36美分。两位分析师对该季度的平均预期是每股亏损 19 美分。* 营收同比下降 61%，为 11.703 万美元；分析师预期为 20 万美元。* Soligenix Inc 公布的本季度每股收益为亏损 18 美分。* 该公司当季亏损 192 万美元。* Soligenix Inc 本季度股价下跌了 33.5%，今年迄今为止下跌了 47.3%。华尔街对 Soligenix Inc 的 12 个月目标价中位数为 3.50 美元。本摘要由 LSEG 数据于世界协调时 5 月 13 日中午 12:31 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2434185388","title":"Soligenix Inc    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434185388","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434185388?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:14","pubTimestamp":1715343279,"startTime":"0","endTime":"0","summary":"   * ) Soligenix公司   预计在5月13日公布截至2024年3月31日的业绩时，(，季度收入将出现下降。* LSEG 分析师对 Soligenix 公司的平均预期是每股亏损 19 美分。* 一位分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Soligenix Inc 的 12 个月目标价中位数为 3.50 美元，高于上一次 0.41 美元的收盘价。5月10日 - 本摘要于北京时间 5 月 10 日 12:14 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX"],"gpt_icon":0},{"id":"2401955133","title":"BUZZ-美国食品和药物管理局授予炎症性疾病药物 \"快速通道 \"标签，Soligenix 公司业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2401955133","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2401955133?lang=zh_cn&edition=full","pubTime":"2024-01-08 21:26","pubTimestamp":1704720364,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月8日 - ** Soligenix公司  股价盘前上涨20.8%至97美分** 药物开发商称美国食品及药物管理局已授予 (link) \"快速通道 \"称号，用于治疗白塞氏病的口腔病变** 白塞氏病是一种罕见的炎症，会导致血管受损、口腔溃疡、皮疹、眼睛和关节疼痛。** 快速通道是美国食品及药物管理局为治疗严重或危及生命的疾病的药物保留的一种指定，可加快对药物的审查** 公司计划在 2024 年启动中期研究** 截至上周五收盘，该公司股价在过去12个月中下跌了88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soligenix.com","stockEarnings":[{"period":"1week","weight":-0.1434},{"period":"1month","weight":-0.5496},{"period":"3month","weight":-0.7076},{"period":"6month","weight":-0.8436},{"period":"1year","weight":-0.8002},{"period":"ytd","weight":-0.8126}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Soligenix, Inc.是一家临床阶段生物制药公司，成立于1987年，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.130569},{"month":2,"riseRate":0.625,"avgChangeRate":-0.04077},{"month":3,"riseRate":0.25,"avgChangeRate":-0.095252},{"month":4,"riseRate":0.125,"avgChangeRate":-0.149397},{"month":5,"riseRate":0.25,"avgChangeRate":-0.127977},{"month":6,"riseRate":0.5,"avgChangeRate":-0.097746},{"month":7,"riseRate":0.625,"avgChangeRate":0.172173},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.062705},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.01391},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.031066},{"month":11,"riseRate":0.571429,"avgChangeRate":0.165289},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.112298}],"exchange":"NASDAQ","name":"Soligenix, Inc.","nameEN":"Soligenix, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Soligenix, Inc.,SNGX,Soligenix, Inc.股票,Soligenix, Inc.股票老虎,Soligenix, Inc.股票老虎国际,Soligenix, Inc.行情,Soligenix, Inc.股票行情,Soligenix, Inc.股价,Soligenix, Inc.股市,Soligenix, Inc.股票价格,Soligenix, Inc.股票交易,Soligenix, Inc.股票购买,Soligenix, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}